Showing results (1781-1790 of 2,755) with videos related to

Sort By:
Pageof 276
Pharmacogenomics|December 16, 2005
Microarray expression technology: from start to finishGareth Elvidge
Pharmacogenomics|October 26, 2022
The revolution of pharmaco-omics: ready to open new avenues in materializing precision medicine?Georgia Ragia, Vangelis G Manolopoulos
Pharmacogenomics|October 26, 2022
Diversity of pharmacogenomic variants affecting warfarin metabolism in Sri LankansPriyanga Ranasinghe, Nirmala Sirisena, Vidarsha Senadeera, et al.
Pharmacogenomics|June 20, 2025
Genetic polymorphisms and adverse reactions to antituberculosis therapyHannah M Gunter, Phuti Choshi, Tafadzwa Chimbetete, et al.
Pharmacogenomics|December 31, 2025
Association between ABCG2 polymorphisms and allopurinol response in gout patients: a systematic review and meta-analysisJia Wen Lee, Muhammad Danish Badrul Hisham, Xin Yee Low, et al.
Pharmacogenomics|December 15, 2025
Selpercatinib for RET-positive advanced pancreatic cancer detected by liquid biopsy: a case-based insightTarek Assi, Tania Moussa, Cendrella Bou-Orm, et al.
Pharmacogenomics|April 16, 2025
Association of SOD1 rs36232792 with opioid use disorder and a novel PCR-RFLP method for SOD2 rs5746136Seval Küçükparmaksız, Dilek Kaya Akyüzlü, Selin Özkan Kotiloğlu, et al.
Pharmacogenomics|May 27, 2025
Hypertension precision medicine: the promise and pitfalls of pharmacogenomicsNhu Ngoc Le, Iain Frater, Stefanie Lip, et al.
Pharmacogenomics|March 31, 2025
Impact of CYP2C19 polymorphism testing on the risk of stent thrombosis in patients with carotid artery stentingHuai Wu Yuan, Xia Huang, Min Ying Pan, et al.
Pharmacogenomics|November 13, 2025
Pharmacogenetic markers of PEG-asparaginase toxicity in Brazilian pediatric ALL: insights from a multicenter prospective cohort studyDaiane Keller Cecconello, Klerize Anecely de Souza Silva, Evelin Cristine Mendonça de Senna, et al.
Pageof 276